申请人:FORMA Therapeutics, Inc.
公开号:US10875848B2
公开(公告)日:2020-12-29
The present disclosure is directed to inhibitors of FASN. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of FASN. For instance, the disclosure is concerned with compounds and compositions for inhibition of FASN, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of FASN, and methods of synthesis of these compounds.
本公开涉及 FASN 的抑制剂。这些化合物可用于治疗与抑制 FASN 有关的疾病或紊乱。例如,本公开涉及用于抑制 FASN 的化合物和组合物,治疗、预防或改善与 FASN 抑制相关的疾病或紊乱的方法,以及合成这些化合物的方法。